好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Machine Learning Model Including Questionnaire and Structural Imaging Data Predicts Headache Improvement in Patients with Acute Post-traumatic Headache Attributed to Mild Traumatic Brain Injury
Headache
P8 - Poster Session 8 (11:45 AM-12:45 PM)
2-002
To assess the accuracy of a model including clinical questionnaire and brain structural measures for predicting headache improvement in patients with acute post-traumatic headache (aPTH) attributed to mild traumatic brain injury (mTBI).

Our prior work demonstrated that questionnaires assessing psychosocial symptoms have utility of predicting PTH persistence. Here, we aimed to determine whether classification accuracy was improved when adding structural brain measures to the model.

Adults with aPTH (enrolled 0-59 days post-mTBI) underwent T1-weighted brain MRI and completed three selected questionnaires (Sports Concussion Assessment Tool-symptom checklist, Pain Catastrophizing Scale, and the Trait Anxiety Inventory Scale). Total and sub-scores of questionnaires and automated segmentations of regional brain volume, thickness, curvature, and area measures were used to train a dimension reduction model followed by prediction models of headache improvement. In addition, aPTH vs healthy control (HC) brain imaging data were compared.

43 patients with aPTH (mean age=43.0, SD=12.4) and 61 HC were enrolled (mean age= 39.1, SD=12.8). At three-month follow-up, 26 aPTH patients had headache improvement and 17 did not. The final model trained on questionnaire data and brain measurements achieved cross-validation Area Under the Curve classification accuracy of 0.801 for predicting headache improvement. The most highly contributing model features included questionnaires assessing psychosocial symptoms and brain structural measurements including curvature and thickness in of superior, middle, and inferior temporal, fusiform, inferior parietal, and lateral occipital regions. At baseline, those with aPTH who improved by three months had less severe symptoms of mTBI, pain catastrophizing, and anxiety than those who did not improve. Furthermore, aPTH patients whose headaches did not improve had significantly greater baseline differences in brain structure vs. HC compared to those whose headaches did improve vs. HC.  

A model including clinical questionnaire data and measures of brain structure accurately predicted three-month headache improvement in patients with aPTH.
Authors/Disclosures
Catherine D. Chong, PhD, FAAN
PRESENTER
Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP.
Jing Li (Georgia Institute of Technology) Jing Li has nothing to disclose.
Todd J. Schwedt, MD, FAAN (Mayo Clinic) Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. Dr. Schwedt has stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Visar Berisha Visar Berisha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Visar Berisha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Visar Berisha has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Aural Analytics. Visar Berisha has received stock or an ownership interest from Aural Analytics. The institution of Visar Berisha has received research support from Boheringer Ingelheim. Visar Berisha has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Teresa Wu (Arizona State University) Teresa Wu has nothing to disclose.
Gina Dumkrieger, PhD (Mayo Clinic) Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Katherine Ross (Phoenix VA Health Care System) Katherine Ross has nothing to disclose.
Lingchao Mao (Georgia Tech) Ms. Mao has nothing to disclose.